Veterinary Medicine Information website

FILAVAC MYX L JF613 SUSPENSION A DILUER ET SOLVANT POUR SUSPENSION INJECTABLE POUR LAPINS

Authorised
  • Myxoma virus, strain JF613, Live

Product identification

Medicine name:
FILAVAC MYX L JF613 SUSPENSION A DILUER ET SOLVANT POUR SUSPENSION INJECTABLE POUR LAPINS
Active substance:
  • Myxoma virus, strain JF613, Live
Target species:
  • Rabbit
  • Rabbit (for reproduction)
Route of administration:
  • Intradermal use

Product details

Active substance and strength:
  • Myxoma virus, strain JF613, Live
    3.50
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Rabbit
      • All relevant tissues
        0
        day
    • Rabbit (for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AD02
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Filavie
Marketing authorisation date:
Manufacturing sites for batch release:
  • Filavie
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9660163 5/2018
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/06/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 10/04/2026

fr-puar-600000044315-np-rpe651-fr.pdf

French (PDF)
Published on: 7/01/2026
Download